Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
brain neoplasms/диария
Линкът е запазен в клипборда
10 резултата
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
This application is a .sctn. 371 of International Application No. PCT/IB2015/056905, filed 9 Sep. 2015, which claims the priority of PCT/CN2015/086995, filed 14 Aug. 2015, and PCT/CN2014/086197, filed 10 Sep. 2014, which are incorporated herein in their entireties.
FIELD OF INVENTION
This invention
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
This application is a .sctn.371 of International Application No. PCT/CN2015/089332, filed 10 Sep. 2015, which claims the priority of PCT/CN2014/000834, filed 10 Sep. 2014, which are incorporated herein in their entireties.
FIELD OF INVENTION
This invention relates to novel compounds which are
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
This application is a 371 of International Application No. PCT/IB2014/059817, filed 14 Mar. 2014, which claims priority of PCT/CN2014/072449, filed 24 Feb. 2014; PCT/CN2013/090059, filed 20 Dec. 2013; and PCT/CN2013/072683, filed 15 Mar. 2013.
FIELD OF INVENTION
This invention relates to novel
Най-пълната база данни за лечебни билки, подкрепена от науката
- Работи на 55 езика
- Билкови лекове, подкрепени от науката
- Разпознаване на билки по изображение
- Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
- Прочетете научни публикации, свързани с вашето търсене
- Търсете лечебни билки по техните ефекти
- Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите
Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания
